Properties
Description
Icatibant inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets bradykinin B2 receptor (B2R).
Molecular Formula
C59H89N19O13S
Targets
Bradykinin B2 receptor (B2R)
Applications
Icatibant can be studied for its effect on blocking the activity of bradykinin, a substance in the body that contributes to the development of angioedema symptoms.